Category: business

business

Analysis, BioTech, business, Earnings

Aegerion Pharmaceuticals (NASDAQ:AEGR) Curbs Losses in Quarter

Aegerion Pharmaceuticals (NASDAQ:AEGR) is lower after it reported a Q4 loss that was smaller than analysts had expected and set a FY14 sales guidance that straddled estimates. Shares are down 11.48% at $58.73 with a 52-week range of $28.33 – $101.00. In the quarter, the biopharmaceutical company had a non-GAAP loss of $0.14 per share, down from a loss of $0.71 the year earlier and … Continue reading Aegerion Pharmaceuticals (NASDAQ:AEGR) Curbs Losses in Quarter

Ryan Holtz
Analysis, BioTech, business, Finance

Markets Watch: Del Frisco’s Restaurant (NASDAQ:DFRG) Hits Record High

Del Frisco’s Restaurant (NASDAQ:DFRG) reached a record high Wednesday after reporting an improved Q4 year-over-year but fell short of analysts’ expectations. The company also provided fiscal 2014 earnings guidance below Street estimates. Shares are up 0.74% at $24.44, reaching an all-time high of $25.64. The company, which owns and operates Del Frisco’s Double Eagle Steak House, Sullivan’s Steakhouse, and Del Frisco’s Grille, reported Q4 adjusted earnings … Continue reading Markets Watch: Del Frisco’s Restaurant (NASDAQ:DFRG) Hits Record High

John Meady
BioTech, business, Earnings, Finance

Transocean (NYSE: RIG) and Dollar Tree (NASDAQ: DLTR) Highlight After-Market Earnings

Transocean Ltd. (NYSE: RIG) is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect very active trading in the issue immediately following its quarterly earnings announcement. Historical earnings event related premarket and after-hours trading activity in RIG indicates that the price change in the extended hours is likely to be of limited value in forecasting additional … Continue reading Transocean (NYSE: RIG) and Dollar Tree (NASDAQ: DLTR) Highlight After-Market Earnings

Mark Doerr
Analysis, BioTech, business, software

Investor’s Alert: Abercrombie & Fitch (NYSE:ANF), HP (NYSE:HP)

Shares in Abercrombie & Fitch (NYSE: ANF) are up almost 8% pre-market after the retailer reported Q4 earnings that topped expectations. The company said adjusted non-GAAP net income was $104.3 million, or $1.34 per diluted share, more than the $1.05 analysts had been expecting, according to Capital IQ. Q4 GAAP net income was $66.1 million, or $0.85 for the thirteen weeks ended February 1, 2014, … Continue reading Investor’s Alert: Abercrombie & Fitch (NYSE:ANF), HP (NYSE:HP)

Jayne Crisman
FB Nasdaq FB Facebook
Analysis, BioTech, business, Earnings

Trader’s Watch List: ExamWorks, JAKKS Pacific, Inc

Shares of ExamWorks (NYSE: EXAM) jumped to a new all-time high Wednesday, after the provider of independent medical examinations late Tuesday reported a narrowed Q4 net loss that was smaller than expected while revenue topped Street estimates and the company forecast Q1 and 2014 revenue above analysts’ expectations. EXAM was up 17% at $35.76 recently, after hitting the fresh record at $36.85. The company posted … Continue reading Trader’s Watch List: ExamWorks, JAKKS Pacific, Inc

Mark Doerr
Analysis, BioTech, business

Trader’s Alert – Dyax Corp, Boeing, Tyco

Dyax Corp (NASDAQ:DYAX) shares rose 8.1% to $10.99, their highest price since mid-2004, after positive Phase 1a study results of DX-2930, a treatment for hereditary angioedema attacks. The first-in-human clinical study of DX-2930 met all objectives of assessing safety, tolerability and pharmacokinetics and showed it well tolerated at all dose levels. Pharmacokinetic results demonstrated that DX-2930 has linear, dose-dependent exposure and a mean elimination half-life … Continue reading Trader’s Alert – Dyax Corp, Boeing, Tyco

Chris Lewis